Go Pro

Firefly Neuroscience (AIFF) Competitors

Firefly Neuroscience logo
$1.21 -0.02 (-1.63%)
Closing price 06/30/2026 04:00 PM Eastern
Extended Trading
$1.23 +0.02 (+1.65%)
As of 04:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AIFF vs. DH, GEG, FATN, AEYE, and MTC

Should you buy Firefly Neuroscience stock or one of its competitors? MarketBeat compares Firefly Neuroscience with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Firefly Neuroscience include Definitive Healthcare (DH), Great Elm Group (GEG), Fatpipe Inc/UT (FATN), Audioeye (AEYE), and MMTec (MTC). These companies are all part of the "computer software" industry.

How does Firefly Neuroscience compare to Definitive Healthcare?

Firefly Neuroscience (NASDAQ:AIFF) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Definitive Healthcare has a consensus target price of $2.47, indicating a potential upside of 197.44%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than Firefly Neuroscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Firefly Neuroscience
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Definitive Healthcare
4 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
1.89

Firefly Neuroscience has higher earnings, but lower revenue than Definitive Healthcare. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Firefly Neuroscience$1.14M16.57-$19.88M-$0.63N/A
Definitive Healthcare$241.52M0.36-$138.93M-$1.62N/A

Definitive Healthcare has a net margin of -76.04% compared to Firefly Neuroscience's net margin of -565.40%. Definitive Healthcare's return on equity of 4.04% beat Firefly Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Firefly Neuroscience-565.40% -94.68% -73.51%
Definitive Healthcare -76.04%4.04%1.99%

In the previous week, Firefly Neuroscience and Firefly Neuroscience both had 2 articles in the media. Firefly Neuroscience's average media sentiment score of 1.62 beat Definitive Healthcare's score of 0.63 indicating that Firefly Neuroscience is being referred to more favorably in the media.

Company Overall Sentiment
Firefly Neuroscience Very Positive
Definitive Healthcare Positive

Firefly Neuroscience has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market.

Summary

Definitive Healthcare beats Firefly Neuroscience on 12 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to Great Elm Group?

Great Elm Group (NASDAQ:GEG) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

Great Elm Group has higher revenue and earnings than Firefly Neuroscience. Great Elm Group is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Great Elm Group$16.32M4.19$12.89M-$0.82N/A
Firefly Neuroscience$1.14M16.57-$19.88M-$0.63N/A

Great Elm Group has a net margin of -100.48% compared to Firefly Neuroscience's net margin of -565.40%. Great Elm Group's return on equity of -54.63% beat Firefly Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Great Elm Group-100.48% -54.63% -25.87%
Firefly Neuroscience -565.40%-94.68%-73.51%

In the previous week, Firefly Neuroscience had 1 more articles in the media than Great Elm Group. MarketBeat recorded 2 mentions for Firefly Neuroscience and 1 mentions for Great Elm Group. Great Elm Group's average media sentiment score of 1.92 beat Firefly Neuroscience's score of 1.62 indicating that Great Elm Group is being referred to more favorably in the media.

Company Overall Sentiment
Great Elm Group Very Positive
Firefly Neuroscience Very Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Great Elm Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Firefly Neuroscience
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

52.8% of Great Elm Group shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 49.7% of Great Elm Group shares are owned by company insiders. Comparatively, 6.4% of Firefly Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Great Elm Group has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Summary

Great Elm Group beats Firefly Neuroscience on 9 of the 13 factors compared between the two stocks.

How does Firefly Neuroscience compare to Fatpipe Inc/UT?

Fatpipe Inc/UT (NASDAQ:FATN) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Fatpipe Inc/UT currently has a consensus target price of $10.00, indicating a potential upside of 58.73%. Given Fatpipe Inc/UT's stronger consensus rating and higher possible upside, equities research analysts plainly believe Fatpipe Inc/UT is more favorable than Firefly Neuroscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fatpipe Inc/UT
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Firefly Neuroscience
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Fatpipe Inc/UT has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Fatpipe Inc/UT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fatpipe Inc/UT$19.21M4.60$4.97M$0.3518.00
Firefly Neuroscience$1.14M16.57-$19.88M-$0.63N/A

Fatpipe Inc/UT has a beta of 2.4, meaning that its share price is 140% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Fatpipe Inc/UT has a net margin of 25.88% compared to Firefly Neuroscience's net margin of -565.40%. Fatpipe Inc/UT's return on equity of 28.85% beat Firefly Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Fatpipe Inc/UT25.88% 28.85% 19.45%
Firefly Neuroscience -565.40%-94.68%-73.51%

In the previous week, Firefly Neuroscience had 1 more articles in the media than Fatpipe Inc/UT. MarketBeat recorded 2 mentions for Firefly Neuroscience and 1 mentions for Fatpipe Inc/UT. Firefly Neuroscience's average media sentiment score of 1.62 beat Fatpipe Inc/UT's score of 0.94 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company Overall Sentiment
Fatpipe Inc/UT Positive
Firefly Neuroscience Very Positive

Summary

Fatpipe Inc/UT beats Firefly Neuroscience on 11 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to Audioeye?

Audioeye (NASDAQ:AEYE) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

Audioeye has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Audioeye has a net margin of -9.05% compared to Firefly Neuroscience's net margin of -565.40%. Audioeye's return on equity of 71.24% beat Firefly Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Audioeye-9.05% 71.24% 11.35%
Firefly Neuroscience -565.40%-94.68%-73.51%

In the previous week, Audioeye and Audioeye both had 2 articles in the media. Firefly Neuroscience's average media sentiment score of 1.62 beat Audioeye's score of 0.47 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Audioeye
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Firefly Neuroscience
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Audioeye presently has a consensus price target of $14.63, indicating a potential upside of 151.72%. Given Audioeye's stronger consensus rating and higher possible upside, research analysts plainly believe Audioeye is more favorable than Firefly Neuroscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Audioeye
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Firefly Neuroscience
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

51.1% of Audioeye shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 25.9% of Audioeye shares are owned by company insiders. Comparatively, 6.4% of Firefly Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Audioeye has higher revenue and earnings than Firefly Neuroscience. Audioeye is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Audioeye$40.31M1.80-$3.08M-$0.29N/A
Firefly Neuroscience$1.14M16.57-$19.88M-$0.63N/A

Summary

Audioeye beats Firefly Neuroscience on 12 of the 15 factors compared between the two stocks.

How does Firefly Neuroscience compare to MMTec?

MMTec (NASDAQ:MTC) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

MMTec has a beta of -0.26, meaning that its stock price is 126% less volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

In the previous week, Firefly Neuroscience had 1 more articles in the media than MMTec. MarketBeat recorded 2 mentions for Firefly Neuroscience and 1 mentions for MMTec. MMTec's average media sentiment score of 1.89 beat Firefly Neuroscience's score of 1.62 indicating that MMTec is being referred to more favorably in the media.

Company Overall Sentiment
MMTec Very Positive
Firefly Neuroscience Very Positive

MMTec has a net margin of 0.00% compared to Firefly Neuroscience's net margin of -565.40%. MMTec's return on equity of 0.00% beat Firefly Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
MMTecN/A N/A N/A
Firefly Neuroscience -565.40%-94.68%-73.51%

0.3% of MMTec shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 12.8% of MMTec shares are owned by insiders. Comparatively, 6.4% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Firefly Neuroscience has higher revenue and earnings than MMTec.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MMTec$810K77.75-$56.08MN/AN/A
Firefly Neuroscience$1.14M16.57-$19.88M-$0.63N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MMTec
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Firefly Neuroscience
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

MMTec beats Firefly Neuroscience on 6 of the 11 factors compared between the two stocks.

Get Firefly Neuroscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIFF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIFF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIFF vs. The Competition

MetricFirefly NeuroscienceTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$19.19M$4.22B$6.83B$12.45B
Dividend YieldN/A2.09%3.16%6.16%
P/E Ratio-1.9242.4330.2624.87
Price / Sales16.5747.80364.40102.84
Price / CashN/A37.0523.5658.59
Price / Book2.124.755.896.54
Net Income-$19.88M$31.79M$203.69M$336.70M
7 Day Performance1.68%0.90%0.71%2.81%
1 Month Performance-29.24%-10.15%-4.71%0.58%
1 Year Performance-59.93%21.52%26.51%31.29%

Firefly Neuroscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIFF
Firefly Neuroscience
0.4352 of 5 stars
$1.21
-1.6%
N/A-57.2%$19.19M$1.14MN/AN/A
DH
Definitive Healthcare
2.907 of 5 stars
$0.76
+3.1%
$2.77
+264.0%
-78.7%$77.79M$241.52MN/A970
GEG
Great Elm Group
0.4866 of 5 stars
$2.49
+2.0%
N/A+5.3%$76.51M$16.32MN/A380
FATN
Fatpipe Inc/UT
4.5338 of 5 stars
$5.44
-0.2%
$10.00
+83.8%
N/A$76.50M$19.21M15.54154
AEYE
Audioeye
3.4678 of 5 stars
$6.13
+2.5%
$14.63
+138.6%
-50.1%$74.71M$40.31MN/A110

Related Companies and Tools


This page (NASDAQ:AIFF) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners